Literature DB >> 19530118

Evolution of the BK polyomavirus: epidemiological, anthropological and clinical implications.

Yoshiaki Yogo1, Chie Sugimoto, Shan Zhong, Yukio Homma.   

Abstract

BK polyomavirus (BKV) is essentially ubiquitous in all human populations worldwide. Asymptomatic infection with this virus occurs during early childhood, leading to life-long persistence in the kidney. BKV has four subtypes that can be identified using serological and genotyping methods. The evolutionary aspects of BKV have remained poorly understood due to the limited availability of BKV genomes, since urinary excretion of BKV DNA is detected primarily in immunocompromised individuals. However, we have found that BKV DNA sequences can often be amplified from non-immunocompromised elderly individuals, using a highly sensitive polymerase chain reaction (PCR) with highly concentrated urinary DNA as the source of viral DNA. Using this approach, we have PCR-amplified and sequenced a large number of partial and complete BKV genomes from various human populations worldwide and conducted a series of evolutionary studies using these sequences. We have shown that subtypes I and IV evolved into four and six subgroups, respectively, with each having a close relationship with a particular human population. In addition, we have provided evidence supporting the hypothesis that BKV strains with the archetypal transcriptional control region (TCR) circulate in the human population. In this review, we describe these findings and discuss their epidemiological, anthropological and clinical implications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19530118     DOI: 10.1002/rmv.613

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  23 in total

1.  Impact of genomic sequence variability on quantitative PCR assays for diagnosis of polyomavirus BK infection.

Authors:  P Randhawa; J Kant; R Shapiro; H Tan; A Basu; C Luo
Journal:  J Clin Microbiol       Date:  2011-09-28       Impact factor: 5.948

Review 2.  BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.

Authors:  George R Ambalathingal; Ross S Francis; Mark J Smyth; Corey Smith; Rajiv Khanna
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

3.  Development and evaluation of a BK polyomavirus serotyping assay using Luminex technology.

Authors:  Herman F Wunderink; Caroline S de Brouwer; Els van der Meijden; Diana V Pastrana; Aloysius C M Kroes; Christopher B Buck; Mariet C W Feltkamp
Journal:  J Clin Virol       Date:  2018-12-01       Impact factor: 3.168

Review 4.  BK polyomavirus diversity-Why viral variation matters.

Authors:  Jason T Blackard; Stella M Davies; Benjamin L Laskin
Journal:  Rev Med Virol       Date:  2020-03-03       Impact factor: 6.989

5.  Polymorphisms of the BK virus subtypes and their influence on viral in vitro growth efficiency.

Authors:  Sara Tremolada; Serena Delbue; Sara Larocca; Camilla Carloni; Francesca Elia; Kamel Khalili; Jennifer Gordon; Pasquale Ferrante
Journal:  Virus Res       Date:  2010-02-04       Impact factor: 3.303

Review 6.  Chronic viral infection and primary central nervous system malignancy.

Authors:  Robert Saddawi-Konefka; John R Crawford
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

7.  Functional Upregulation of the DNA Cytosine Deaminase APOBEC3B by Polyomaviruses.

Authors:  Brandy Verhalen; Gabriel J Starrett; Reuben S Harris; Mengxi Jiang
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

8.  Human polyomavirus KI, WU, BK, and JC in healthy volunteers.

Authors:  Giselle P A Pena; Gabriella S Mendes; Helver G Dias; Lucas S Gavazzoni; Ariane R Amorim; Norma Santos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-10-18       Impact factor: 3.267

9.  BK polyomavirus genotypes represent distinct serotypes with distinct entry tropism.

Authors:  Diana V Pastrana; Upasana Ray; Thomas G Magaldi; Rachel M Schowalter; Nicolas Çuburu; Christopher B Buck
Journal:  J Virol       Date:  2013-07-10       Impact factor: 5.103

Review 10.  CC and CXC chemokines play key roles in the development of polyomaviruses related pathological conditions.

Authors:  Mohammad Hassan Mohammadi; Ashraf Kariminik
Journal:  Virol J       Date:  2021-06-03       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.